Simplex Trading’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.18K Buy
1,100
+200
+22% +$427 ﹤0.01% 8155
2025
Q4
$1.45K Sell
900
-3,400
-79% -$5.34K ﹤0.01% 7929
2025
Q3
$7K Sell
4,300
-800
-16% -$1.29K ﹤0.01% 8122
2025
Q2
$6K Sell
5,100
-1,100
-18% -$1.6K ﹤0.01% 7655
2025
Q1
$7K Buy
+6,200
New +$16.2K ﹤0.01% 7344
2024
Q4
Sell
-14,400
Closed -$47K 9185
2024
Q3
$47K Sell
14,400
-46,700
-76% -$182K ﹤0.01% 5935
2024
Q2
$259K Buy
61,100
+54,200
+786% +$528K ﹤0.01% 4390
2024
Q1
$101K Buy
+6,900
New +$104K ﹤0.01% 5562
2023
Q4
Sell
-6,700
Closed -$31K 9419
2023
Q3
$31K Sell
6,700
-20,000
-75% -$99.6K ﹤0.01% 6227
2023
Q2
$142K Buy
26,700
+7,400
+38% +$45.6K ﹤0.01% 4680
2023
Q1
$138K Sell
19,300
-2,800
-13% -$16.9K ﹤0.01% 4778
2022
Q4
$148K Buy
22,100
+18,800
+570% +$103K ﹤0.01% 4603
2022
Q3
$11K Sell
3,300
-20,800
-86% -$79.6K ﹤0.01% 8153
2022
Q2
$71K Buy
24,100
+19,700
+448% +$104K ﹤0.01% 6020
2022
Q1
$38K Buy
4,400
+3,400
+340% +$37.5K ﹤0.01% 7505
2021
Q4
$16K Sell
1,000
-14,800
-94% -$279K ﹤0.01% 8617
2021
Q3
$445K Hold
15,800
﹤0.01% 4269
2021
Q2
$424K Buy
15,800
+15,582
+7,148% +$456K ﹤0.01% 4415
2021
Q1
$694K Buy
218
+165
+311% +$4.01K ﹤0.01% 2890
2020
Q4
$121K Buy
53
+40
+308% +$921 ﹤0.01% 5249
2020
Q3
$32K Sell
13
-33
-72% -$901 ﹤0.01% 6014
2020
Q2
$128K Buy
46
+15
+48% +$261 ﹤0.01% 4529
2020
Q1
$18K Buy
31
+17
+121% +$154 ﹤0.01% 6048
2019
Q4
$15K Sell
14
-109
-89% -$1.08K ﹤0.01% 6150
2019
Q3
$156K Buy
123
+7
+6% +$101 ﹤0.01% 3831
2019
Q2
$196K Sell
116
-6
-5% -$103 ﹤0.01% 3479
2019
Q1
$219K Buy
+122
New +$2.11K ﹤0.01% 3512
2018
Q3
Sell
-26
Closed -$53K 7788
2018
Q2
$53K Buy
+26
New +$586 ﹤0.01% 4982
2017
Q3
Sell
-201
Closed -$15K 6325
2017
Q2
$15K Buy
+201
New +$3.83K ﹤0.01% 3581
2016
Q3
Sell
-10
Closed -$8K 6194
2016
Q2
$8K Buy
+10
New +$226 ﹤0.01% 3806

Other funds holding MGNX

Simplex Trading's MGNX Position: Q1 2026 in Review

Simplex Trading reduced its MacroGenics (MGNX) stake by 6.5% in Q1 2026, selling an estimated $710 and leaving 4,764 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #7067.

Simplex Trading first reported a position in MGNX in Q2 2016 and has held it in 30 quarters since. The position peaked at $445K in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Simplex Trading held 4,764 shares of MacroGenics worth $13.8K as of Q1 2026.
  • Simplex Trading sold 333 MacroGenics shares in Q1 2026, an estimated $710.
  • MacroGenics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7067 holding.
  • Simplex Trading first reported a position in MacroGenics in Q2 2016 and has held it in 30 quarters since.
  • Simplex Trading's MacroGenics position peaked at $445K in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.